The significance of vasoactive intestinal peptide in immunomodulation.
about
VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humansProtective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritisRole of vasoactive intestinal peptide in osteoarthritisThe Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseEmerging Novel Therapies for Heart FailureLandmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structureMicroglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In VivoVPAC receptors: structure, molecular pharmacology and interaction with accessory proteinsThe neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseasesNeuro-endocrine networks controlling immune system in health and diseaseThe "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabiesManganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Anatomical evidence for enteric neuroimmune interactions in Peyer's patchesNociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamicsTherapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy.Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88)Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 miceVasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesityVasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.Mechanisms of immune privilege in the posterior eye.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsPituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAEVIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections.Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2)Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.Pituitary adenylyl cyclase-activating peptide counteracts hedgehog-dependent motor neuron production in mouse embryonic stem cell cultures.Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice
P2860
Q24609073-08A4082B-F126-462F-A6AB-30DC1FDB66C5Q24812326-78A9EF53-EB67-4A81-8C55-9B300DF72923Q24816927-3B4B27E2-57D3-472D-A632-EEA23ADDD023Q26739694-CF0D7A73-EE09-4EE0-A70E-54865FE9DD11Q26774660-D8FF71B6-6E65-449B-A320-3CA62062A653Q26778111-B2248A6B-BE15-4D7D-8C9C-1FBCAAAA7F49Q26798049-DC6310F4-E1D0-4EBB-9ABD-7BEE98F6E79FQ26798185-41B2DFF4-366D-4055-BA48-5A7D2D39BA66Q26827172-F061E9B2-E108-4829-9D1F-BE78665D276DQ26851670-37CD8762-6727-4B7A-97AC-88E30ED069A7Q27026101-A4D9C232-6925-4282-8212-E2C5C2B11AE2Q28681336-CD7118E8-5664-46F2-BBF5-7FCD1DC2C82EQ31109638-8D974C17-FE69-48E4-B4B7-4F39ECC7AD23Q33278877-B7847CC1-53A1-429E-8849-3E0058A09889Q33554431-E414D30E-14DB-4F1F-A425-B4480623A022Q33643329-D186D244-4509-40CA-8641-0832C6D765FBQ33652057-E98368D7-2CC6-4BA5-A0BB-062ABC7FF0A6Q33712853-D7D00A2F-1AA1-42A3-A74B-3A9893012F30Q33826520-C5F78080-D9B1-4E1F-B335-8AECB6410104Q33870752-215485A9-DACB-4CC5-B97B-B2AA49962AF1Q33931602-236F9A06-8F94-4D6D-B05B-35D1BB579A5BQ34015572-E941E269-138F-4B2C-AE79-A403C8E8C89AQ34015933-9B653F69-17E1-474F-9C9F-9B1A0A8C1B3BQ34157261-3813D88B-0B51-4189-A25B-F9AC40C24AD2Q34238010-800AD09D-8D84-415B-9602-ECC4F5972DD3Q34277527-6D67893B-798F-4DEA-AA4F-F5C1C52DBD08Q34307289-98C72280-1003-445F-927E-2A74D75CCBECQ34320335-A569B577-A13C-4A81-A6E0-76A199782E2CQ34504753-D5156018-F89B-4989-B56B-4DBCED026D12Q34566740-496CF3B7-CD7D-4123-AFBD-E08EAAA5FCB5Q34645842-95B6C1F4-1C06-469E-8B83-310801332814Q34684150-09562E13-8CF1-4D3C-A85B-A1F4A0D1AB35Q34749251-4CB8865B-6C63-417F-B2DE-C2333BD6BCD2Q34765538-6FEF56D5-B00C-4C5E-BA00-AE37DA6DA893Q34975674-CEF6D33E-EA83-4EAE-A998-044753654214Q34979549-D65DCE30-B4CF-4F25-9049-6397B11AE8D7Q35001530-D72D13C6-7B56-4444-A092-B372BC0D03E3Q35088106-697FF668-C036-424C-98B4-11B02A2D52C5Q35091496-2FCD1D78-DF4C-4914-8AFF-2943CD09FB76Q35094493-2B6DBA53-2330-4470-81FD-634FD7E05B59
P2860
The significance of vasoactive intestinal peptide in immunomodulation.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The significance of vasoactive intestinal peptide in immunomodulation.
@ast
The significance of vasoactive intestinal peptide in immunomodulation.
@en
The significance of vasoactive intestinal peptide in immunomodulation.
@nl
type
label
The significance of vasoactive intestinal peptide in immunomodulation.
@ast
The significance of vasoactive intestinal peptide in immunomodulation.
@en
The significance of vasoactive intestinal peptide in immunomodulation.
@nl
prefLabel
The significance of vasoactive intestinal peptide in immunomodulation.
@ast
The significance of vasoactive intestinal peptide in immunomodulation.
@en
The significance of vasoactive intestinal peptide in immunomodulation.
@nl
P356
P1476
The significance of vasoactive intestinal peptide in immunomodulation.
@en
P2093
Doina Ganea
P304
P356
10.1124/PR.56.2.7
P577
2004-06-01T00:00:00Z